Targeting BCR-ABL and JAK2 in Ph+ ALL

被引：3
|
作者：
Hantschel, Oliver [1 ]
机构：
[1] Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland
来源：
BLOOD | 2015年 / 125卷 / 09期
关键词：
INHIBITION; JAK2-STAT5; IMATINIB; CELLS;
D O I：
10.1182/blood-2014-12-617548
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1362 / 1363
页数：3
相关论文
共 50 条
  • [31] Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib
    Luque Paz, Damien
    Ianotto, Jean-Christophe
    Chauveau, Aurelie
    Guibourg, Briac
    Lecucq, Lydie
    Lippert, Eric
    Ugo, Valerie
    ANNALS OF HEMATOLOGY, 2016, 95 (02) : 349 - 350
  • [32] Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib
    Damien Luque Paz
    Jean-Christophe Ianotto
    Aurélie Chauveau
    Briac Guibourg
    Lydie Lecucq
    Eric Lippert
    Valérie Ugo
    Annals of Hematology, 2016, 95 : 349 - 350
  • [33] BCR-ABL induces normal erythropoiesis in the absence of JAK2.
    Ghaffari, S
    Kitidis, C
    Neubauer, H
    Pfeffer, K
    Lodish, H
    BLOOD, 2000, 96 (11) : 538A - 538A
  • [34] JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
    Traer, Elie
    MacKenzie, Ryan
    Snead, Jennifer
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2010, 116 (21) : 91 - 92
  • [35] Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2
    E Grundschober
    A Hoelbl-Kovacic
    N Bhagwat
    B Kovacic
    R Scheicher
    E Eckelhart
    K Kollmann
    M Keller
    F Grebien
    K-U Wagner
    R L Levine
    V Sexl
    Leukemia, 2014, 28 : 1918 - 1922
  • [36] Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2
    Grundschober, E.
    Hoelbl-Kovacic, A.
    Bhagwat, N.
    Kovacic, B.
    Scheicher, R.
    Eckelhart, E.
    Kollmann, K.
    Keller, M.
    Grebien, F.
    Wagner, K-U
    Levine, R. L.
    Sexl, V.
    LEUKEMIA, 2014, 28 (09) : 1918 - 1922
  • [37] Wnt/Ca2+/NFAT Signaling Maintains Survival of Ph+ Leukemia Cells upon Inhibition of Bcr-Abl
    Gregory, Mark A.
    Phang, Tzu L.
    Neviani, Paolo
    Alvarez-Calderon, Francesca
    Eide, Christopher A.
    O'Hare, Thomas
    Zaberezhnyy, Vadym
    Williams, Richard T.
    Druker, Brian J.
    Perrotti, Danilo
    DeGregori, James
    CANCER CELL, 2010, 18 (01) : 74 - 87
  • [38] Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
    Kim, Hye-Ran
    Choi, Hyun-Jung
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    PLOS ONE, 2013, 8 (01):
  • [39] JAK2-V617F and BCR-ABL -: Double Jeopardy?
    Kraemer, Alwin
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1489 - 1490
  • [40] Emergence of a BCR-ABL Translocation in a Patient With the JAK2V617F Mutation: Evidence for Secondary Acquisition of BCR-ABL in the JAK2V617F Clone
    Yamada, Osamu
    Mahfoudhi, Emna
    Plo, Isabelle
    Ozaki, Kohji
    Nakatake, Mayuka
    Akiyama, Masaharu
    Yamada, Hisashi
    Kawauchi, Kiyotaka
    Vainchenker, William
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) : E76 - E79
12345